Results 181 to 190 of about 198,722 (342)

Bisphenol A Induces DNA Damage and Differential Cytotoxicity in Thyroid Cells: High‐Dose Effects Challenge Regulatory Thresholds

Journal of Applied Toxicology, EarlyView.
ABSTRACT Bisphenol A (BPA), a ubiquitous environmental endocrine disruptor, has been implicated in carcinogenesis; however, its effects on thyroid cells remain unclear. This study investigated BPA‐induced cytotoxicity and genotoxicity in thyroid cell lines, including normal follicular (Nthy‐ori 3‐1), papillary carcinoma (TPC‐1 and BCPAP) and anaplastic
Izabela Fernanda Dal' Bó, Natássia Elena Bufalo, Valdemar Máximo, Laura Sterian Ward   +3 more
wiley   +1 more source

BRAF; MEK [PDF]

Science-Business eXchange, 2012
openaire   +1 more source

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.

Journal of Clinical Oncology, 2018
V. Subbiah, R. Kreitman, Z. Wainberg, J. Cho, J. Schellens, J. Soria, P. Wen, C. Zielinski, M. Cabanillas, G. Urbanowitz, B. Mookerjee, Dazhe Wang, F. Rangwala, B. Keam   +13 more
semanticscholar   +1 more source

Identification of Predictive Factors for Isolated Brain Progression in Patients With Cerebral Metastatic Melanoma After Treatment With Stereotactic Brain Radiotherapy

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Melanomas often metastasize to the brain, leading to a significantly poor prognosis despite advances in local and systemic treatments. In clinical practice, we frequently observe varying response patterns and progression dynamics between cerebral and extra cerebral sites. Objectives This study aims to identify predictive factors for
Manuel Croix, Justine Lequesne, Julien Geffrelot, Anne Dompmartin, Jean Matthieu L'orphelin   +4 more
wiley   +1 more source

BRAF

, 2016
Frank Gaillard, Rohit Sharma, Yuranga Weerakkody   +2 more
openaire   +1 more source

Immunotherapy‐Related Cutaneous Toxicities in Melanoma: A Dermoscopic Perspective

JEADV Clinical Practice, EarlyView.
Dermoscopy serves as a valuable tool in the everyday dermatological and oncological practice for melanoma patients, allowing for the prompt identification of immune‐related cutaneous toxicities and guiding clinicians toward appropriate therapeutic decisions.
Grażyna Kamińska‐Winciorek, Iris Zalaudek, Karolina Zarańska, Bożena Cybulska‐Stopa   +3 more
wiley   +1 more source

A Complete Response to Immunotherapy in a Patient with Locally Advanced Squamous Cell Lung Cancer Harboring a Novel <i>TMEM178B::BRAF</i> Fusion: A Case Report. [PDF]

Diagnostics (Basel)
Redondo-González JC, San Miguel I, Rodríguez-González M, Montero JC, Sayagués JM, Abad Hernández M, Fonseca Sánchez E, Del Barco-Morillo E, Olivares-Hernández A.   +8 more
europepmc   +1 more source

Distinct clinical and genomic profiles of braf mutation subtypes in Chinese colorectal cancer: a retrospective cohort study with cross-population validation. [PDF]

Cell Oncol (Dordr)
Yang W, Duan Y, Huang X, Song W, Qian J, Zeng Y, Guo T, Wu Y, Li H, Zou X, Xu Y.   +10 more
europepmc   +1 more source

BRAF Inhibitor [PDF]

, 2020
openaire   +1 more source

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.

New England Journal of Medicine, 2012
J. Sosman, Kevin B. Kim, L. Schuchter, R. Gonzalez, A. Pavlick, J. Weber, G. McArthur, Thomas E. Hutson, S. Moschos, K. Flaherty, P. Hersey, R. Kefford, D. Lawrence, I. Puzanov, K. Lewis, R. Amaravadi, B. Chmielowski, H. Lawrence, Y. Shyr, Fei Ye, Jiang Li, K. Nolop, Richard J Lee, A. Joe, A. Ribas   +24 more
semanticscholar   +1 more source